Insulet (Nasdaq:PODD) announced today that its board of directors appointed Ashley McEvoy as president and CEO, effective ...

Ypsomed announced today that it agreed to sell its diabetes care business to TecMed for up to approximately $517.7 million ...

Medtronic announced today that it submitted 510(k) applications to the FDA seeking clearance for an interoperable insulin ...

Abbott recently launched a smartphone app that works with both its FreeStyle Libre 2 and FreeStyle Libre 3 CGM systems.

Biolinq has completed its pivotal trial and submitted its wearable biosensor to the FDA for regulatory review.

Medtronic initially won FDA approval in August for its next-generation Simplera CGM. The Simplera platform includes the ...

Tidepool announced today that it secured a new certification for its open-source quality management system, known as qmsOS.

A review of several studies highlighted the role smart infusion pump interoperability can play in medication administration.

Glucotrack (Nasdaq:GCTK) announced today that it intends to participate in a bionic pancreas initiative in Europe.